Bluetongue serotype 3 (BTV-3) vaccination
Information on BTV-3 vaccines for keepers and vets, including permitsrules for reporting vaccinations and licences.
keeping records.
You must report your use of the BTV-3 vaccine. It is against the law to use the vaccine without reporting it.
There are 3 bluetongue serotype (BTV-3) vaccines thatauthorised canfor beuse used in Greatthe Britain. These are:UK:
- Bluevac-3
Bultavo3BULTAVO 3SYVAZULSyvazul BTV 3
WhereGuidance youfor cankeepers
Deciding usewhether BTV-3to vaccinesvaccinate
InWork England,with youyour canvet useto thedetermine Bluevac-3,if bluetongue vaccination Bultavois 3right orfor SYVAZULyour BTVanimals.
You 3can vaccines,also ascheck longthe Battle asBluetongue youcampaign for complymore withinformation theon deciding conditionswhether ofto thevaccinate generalyour licenceanimals.
Administering forvaccines
A vet Englandmust includingprescribe reportingBTV-3 vaccination activity.vaccines.
InAs Scotland,the animal keeper, you can useadminister the Bluevac-3,vaccine Bultavoto 3your oranimals.
You SYVAZULshould use BTVsafe 3practice, vaccines,based ason longthe ascode youof complypractice withon the declarationresponsible includinguse reportingof vaccinationanimal activitymedicines on the farm..
Reporting vaccinations and keeping records
In Wales,England, youWales canand useScotland theyou Bluevac-3,must:
- keep
Bultavoa3recordorofSYVAZULeveryBTVanimal3youvaccines,vaccinateas–longtheasinformation youcomplyneedwithtotherecordconditionsis onofthe generalthelicence for England, general licence for WalesincludingorreportingdeclarationvaccinationforactivityScotland.In - keep
NortherntheseIreland,recordsyouforcanatuseleastthe5Bluevac-3,years -
report
Bultavovaccinations3withinor48SYVAZULhoursBTV–3providingvaccines,detailsasincludinglongtheasindividual animal IDs and vaccine you use
In Northern Ireland you must:
- apply for a specific licence
fortoNorthernobtainIrelandBluetongueandvaccines (DAERA) -
report
vaccinationvaccinationsactivityto DAERA.within 5 working days of vaccinating
AdvisoryGuidance note for vets
The UK, Wales, Scotland and Northern Ireland Chief Veterinary Officers ask all vets to record BTV-3 vaccine vaccine use and inform relevant authorities of any adverse effects.effects.
Veterinarians should read the relevant advisory note for their country before prescribing any any BTV-3 vaccine: vaccine.
Read the:
- advisory note for England
- advisory note for Wales
- advisory note for Scotland
- advisory note for Northern Ireland
Market authorisation
TheseVets vaccinesin wereEngland, authorisedScotland underand exceptionalWales circumstancesshould andnotify thereforeDefra assessmentswithin were7 baseddays onof customisedprescribing requirementsthe forvaccine documentation.
Transitionusing periodthe prescription forof permittedthe BTV-3 vaccine vaccines
reporting form.
MarketingVets authorisationsin forNorthern Ireland should record BTV-3 vaccine vaccinesuse haveeach beenmonth and grantedreturn forthe usecompleted inrecord Greatto Britaintheir andlocal NorthernDAERA Ireland.Direct Office.
Market authorisation
UnauthorisedMarketing authorisations for BTV-3 vaccines (Bluevac-3, vaccinesBULTAVO 3 permittedand Syvazul) have been granted for use subjectin toGreat licenceBritain orand declarationNorthern can:Ireland.
beTransition
importedperiodintoforGreatunauthorisedBritainvaccinesUnauthorised
(England,vaccinesScotlandthatandwereWales)imported underapermituntilbefore October 2025beimportedintoNorthernGreatIrelandBritainunder(31aDecemberpermit2025untilfor31NorthernDecemberIreland)2025can continue to be
usedused,underproviding:a) the
permitlicence oruntildeclaration conditionstheyarereachmetb) the vaccine
theirhasexpirynotdate,exceeded its expiryasdatec) the vaccine
longwas purchased onastheywerepurchasedonthe GreatBritainBritain or NorthernandNorthernIreland markets
You can use authorised vaccines as soon as they are available.
Bluevac-3 suspension for injection for sheep and cattle
Permitted Bluevac-3 product information
ForThe themarketing permittedauthorisation Bluevac-3 product for use during the transition period, you can view the:
summaryofproductcharacteristicsforBluevac-3BTV-3vaccineintheUKpermitforuseofBluevac-3bluetongueserotype3vaccineintheUK
Authorised Bluevac-3 product information
The marketing authorisation for this vaccine is held by CZ Veterinaria S.A.
This vaccineIt has has marketing authorisations for use in Great Britain and Northern Ireland,Ireland.
This andvaccine is for is for the active immunisation of:of:
- sheep - to reduce the viraemia, mortality and clinical signs caused by the serotype 3 of the bluetongue
virusvirus - cattle - to reduce the viraemia against the serotype 3 of the bluetongue virus
TheFind the summary of product characteristics (SPC) for the authorised Bluevac-3 productproduct:
- for Great
isBritain - onavailableonthethe VMD’s Product Information Database (PID).Bultavo - for
3NorthernsuspensionIreland - onforthe EuropeaninjectionMedicinesforAgencysheep(EMA)’sandUnioncattleProduct database
Permitted
Find Bultavoinformation 3on productunauthorised Bluevac-3 vaccine information
Forthat thewas permittedimported Bultavounder 3permit productbefore forOctober use2025 duringinto theGreat transitionBritain period,(31 youDecember can2025 viewfor the:Northern Ireland):
-
summary of product characteristics for
Bultavo3Bluevac-3 BTV-3 vaccinevaccinein the UK - permit for use of
BultavoBluevac-33bluetongue serotype 3 vaccine in the UK
AuthorisedBULTAVO 3 Bultavosuspension 3for productinjection information
for sheep and cattle
The marketing authorisation for thisthe BULTAVO 3 vaccine is held by Boehringer Ingelheim Animal Health UK Limited.
ThisLimited. It vaccine has marketing authorisations for use in Great Britain and Northern Ireland,Ireland.
This andvaccine is for the active immunisation of:of:
- sheep - to reduce viraemia and to prevent clinical signs caused
byby BTV-3 - cattle - to prevent viraemia and to prevent clinical signs caused
byby BTV-3
TheFind the summary of product characteristics (SPC) for the authorised BultavoBULTAVO 3 3 product is available on the the VMD’s Product Information Database (PID) and the European Medicines Agency (EMA)’s Union Product database..
SYVAZUL
Find BTVinformation 3on suspensionunauthorised BULTAVO for3 vaccine injectionthat forwas sheepimported andunder cattle
Permittedpermit Syvazulbefore productOctober information
For2025 theinto permittedGreat SyvazulBritain product(31 forDecember use2025 duringfor theNorthern transition period, you can view the: Ireland):
-
summary of product characteristics
forfor BULTAVO 3 vaccineSYVAZULBTV3vaccinein the UK - permit for use of
SYVAZULBULTAVO 3 vaccineBTV3bluetongueserotype3vaccine in the UK
Authorised Syvazul product- information
BTV 3 suspension for injection for sheep and cattle
The marketing authorisation for thisthe Syvazul vaccine is held by Laboratorios SYVA S.A.U.
ThisS.A.U. It has vaccine has marketing authorisations for use in Great Britain and Northern Ireland.
TheThis Greatvaccine Britain authorised product is for the active immunisation of:of:
- sheep - to reduce viraemia, mortality, clinical signs and lesions caused by bluetongue serotype
33 - cattle - to reduce viraemia caused by bluetongue virus serotype 3
TheFind the summary of product characteristics (SPC) for thethe authorised Syvazul BTV GB-authorised SYVAZUL BTV 3 isproduct:
- for
availableGreatonBritainthe- on the VMD’s Product Information Database.SYVAZUL - for
BTVNorthern3Irelandis- onauthorisedthe EuropeanthroughoutMedicinestheAgencyEU(EMA)’sandUnionaccordingProducttotheWindsorFrameworkdatabase
Find couldinformation beon marketedunauthorised Syvazul BTV in3 vaccine Northernthat Ireland,was forimported theunder activepermit immunisationbefore ofOctober sheep2025 tointo reduceGreat viraemia,Britain mortality,(31 clinicalDecember signs2025 andfor lesionsNorthern caused by bluetongue serotype 3.Ireland):
The
-
summary of product characteristics
(SPC)for Syvazul BTVfor3thevaccineEU-authorisedinSYVAZULtheBTVUK - permit
3forisuseavailableof Syvazul BTVon3theVMD’sbluetongueProductserotypeInformation3Databasevaccineandin theEuropeanMedicinesAgency(EMA)’sUnionProductdatabaseUK.
MovementBluetongue controls and trade restrictionstesting
All trade restrictions still apply to vaccinated animals. You should not test vaccinated animalsanimals within 7 asdays partof vaccination. ofAny sample ataken less pre-movementthan test7 indays after bluetonguevaccination could zoneslead untilto 7false dayspositive afterresults.
Read theirmore vaccination.about Thisbluetongue will prevent interference with BTV-3 monitoring.testing.
Updates to this page
-
31 July 2025 You can use these vaccines in Northern Ireland: updated guidance to include the rules you must follow.
-
24 July 2025 Information has been updated about the transition period for permitted vaccines. Unauthorised BTV-3 vaccines permitted for use subject to licence or declaration can be imported in Northern Ireland under a permit until 31 December 2025. They can continue to be used under permit until they reach their expiry date, as long as they were purchased on the Great Britain and Northern Ireland markets.
-
4 September 2024 First published.
Update history
2026-03-17 11:25
We’ve moved some guidance from other GOV.UK pages onto this page.
2025-07-31 16:27
You can use these vaccines in Northern Ireland: updated guidance to include the rules you must follow.
2025-07-24 09:00
Information has been updated about the transition period for permitted vaccines. Unauthorised BTV-3 vaccines permitted for use subject to licence or declaration can be imported in Northern Ireland under a permit until 31 December 2025. They can continue to be used under permit until they reach their expiry date, as long as they were purchased on the Great Britain and Northern Ireland markets.